Showing 133–144 of 1739 results

BCL 6 (3q27 Gene rearrangement ) Diffuse large B-cell Lymphoma (DLBCL)- Tissue

13,400.00

BCL 6 (3q27 Gene rearrangement ) Diffuse large B-cell Lymphoma (DLBCL)- Tissue

Septiscreen Molecular Detection (Any 20 Pathogens)

13,200.00

Septiscreen Molecular Detection (Any 20 Pathogens)

Neutropenia Panel/Post- Transplant Panel (Any 10 Pathogens) *

13,200.00

Neutropenia Panel/Post- Transplant Panel (Any 10 Pathogens) *

Community Acquired Sepsis Panel ( Aster)

13,200.00

Community Acquired Sepsis Panel ( Aster)

Antibiotic Resistance Molecular Detection Full Panel *

13,200.00

Antibiotic Resistance Molecular Detection Full Panel
*

AML Extended Panel ( 8 Markers) t(15;17) (PML- RARA), t(8;21) (ETO-AML1), inv(16) (CBFB), 11q23 (MLL), inv(3) (MECOM), del(5q) (EGR1), del(7q) (D7S486), BCR/ABL, T(9;22) *

13,000.00

AML Extended Panel ( 8 Markers) t(15;17) (PML- RARA), t(8;21) (ETO-AML1),
inv(16) (CBFB), 11q23 (MLL),
inv(3) (MECOM), del(5q)
(EGR1), del(7q) (D7S486),
BCR/ABL, T(9;22) *

Paraneoplastic Marker- 12 Antigen **

12,935.00

Paraneoplastic Marker- 12 Antigen **

Allergy – Adult (Comprehensive ) Panel **

12,935.00

Allergy – Adult (Comprehensive
) Panel **

Multiple Myeloma Panel- (5 Markers) [del 13q; t(4;14) FGFR3/IGH; t(11;14) CCND1/IGH; t(14;16) MAF/IGH; del 17p]- on enriched CD138+ plasma cells **

12,825.00

Multiple Myeloma Panel- (5 Markers) [del 13q; t(4;14) FGFR3/IGH; t(11;14) CCND1/IGH; t(14;16) MAF/IGH;
del 17p]- on enriched CD138+
plasma cells **

Lymphoma Panel IHC (Comprehensive)

12,600.00

Lymphoma Panel IHC (Comprehensive)

Leukemia -Chronic Lymphoproliferative Disorder, Blood

12,500.00

Leukemia -Chronic Lymphoproliferative Disorder, Blood